American Portfolios Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

American Portfolios Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$3.91K	Hold	520	–	–	﹤0.01%	2917
2022 Q2	$5.23K	Hold	520	–	–	﹤0.01%	2812
2022 Q1	$6.44K	Hold	520	–	–	﹤0.01%	2857
2021 Q4	$11.9K	Sell	520 -5,606	-92%	-$133K	﹤0.01%	2554
2021 Q3	$136K	Hold	6,126	–	–	0.01%	1312
2021 Q2	$79.4K	Hold	6,126	–	–	﹤0.01%	1500
2021 Q1	$79.5K	Buy	6,126 +350	+6%	+$5.08K	﹤0.01%	1406
2020 Q4	$79.9K	Buy	5,776 +5,000	+644%	+$72.8K	﹤0.01%	1240
2020 Q3	$11.4K	Hold	776	–	–	﹤0.01%	1933
2020 Q2	$12.6K	Hold	776	–	–	﹤0.01%	1838
2020 Q1	$11.3K	Hold	776	–	–	﹤0.01%	1758
2019 Q4	$15.7K	Buy	+776	New	+$7.15K	﹤0.01%	1823

Other funds holding AUPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Portfolios Advisors's AUPH Position: Q3 2022 in Review

American Portfolios Advisors held its Aurinia Pharmaceuticals (AUPH) position steady in Q3 2022 at 520 shares worth $3.91K. The position accounts for ﹤0.01% of the portfolio, ranked #2917.

American Portfolios Advisors first reported a position in AUPH in Q4 2019 and has held it in 12 quarters since. The position peaked at $136K in Q3 2021. 189 funds tracked by Wall St. Rank hold AUPH as of Q3 2022.

American Portfolios Advisors held 520 shares of Aurinia Pharmaceuticals worth $3.91K as of Q3 2022.
American Portfolios Advisors left its Aurinia Pharmaceuticals share count unchanged in Q3 2022.
Aurinia Pharmaceuticals made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2917 holding.
American Portfolios Advisors first reported a position in Aurinia Pharmaceuticals in Q4 2019 and has held it in 12 quarters since.
American Portfolios Advisors's Aurinia Pharmaceuticals position peaked at $136K in Q3 2021.
189 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.